Logout
If you want to log out click in LogOut
The hypoxia signaling pathway is a fundamental cellular response activated under low oxygen (hypoxic) conditions. It enables cells to adapt to oxygen deprivation by regulating gene expression programs involved in angiogenesis, metabolism, immune modulation, and survival.
Central to the hypoxia pathway are hypoxia-inducible factors (HIFs), transcription factors that stabilize when oxygen levels drop. Once activated, HIFs regulate a broad network of genes that promote cellular adaptation to hypoxic stress.
Dysregulation of this pathway is strongly associated with cancer progression, ischemic diseases, fibrosis, chronic inflammation, and metabolic disorders.
Hypoxia pathway activity can be efficiently assessed by measuring gene expression of oxygen sensors, HIF targets, and hypoxia-responsive biomarker signatures.
Hypoxia signaling pathway biomarker list
View the genes included in our hypoxia-related qPCR arrays.
The hypoxia signaling pathway regulates:
Cancer
Hypoxia promotes:
Ischemic disorders
Hypoxia signaling contributes to tissue repair mechanisms following stroke, myocardial infarction, and vascular injury.
Chronic respiratory diseases
Persistent hypoxia alters pulmonary remodeling and vascular function.
Metabolic diseases
Hypoxic adipose tissue contributes to insulin resistance and metabolic inflammation
Understanding the physiological context is critical:
Each condition activates distinct components of the hypoxia pathway
Targeting hypoxia signaling is an emerging strategy in:
Accurate hypoxia biomarker profiling is essential for patient stratification and treatment monitoring
At AnyGenes®, we provide high-performance qPCR arrays and customizable SignArrays® dedicated to hypoxia pathway analysis.
Our solutions enable researchers to:
What can be analyzed?
Scientific data is only as powerful as the analysis behind it.
AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.
What does it allow you to do?
Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
[email protected]
to initiate your project.
The hypoxia signaling pathway is a cellular oxygen-sensing mechanism activated under low oxygen conditions. It regulates gene expression programs that promote angiogenesis, metabolic adaptation, immune modulation, and cell survival through hypoxia-inducible factors (HIFs).
Under low oxygen levels, HIF-α subunits stabilize and dimerize with HIF-β. The complex translocates to the nucleus and activates hypoxia-responsive genes such as VEGF and glycolytic enzymes, enabling cells to adapt to oxygen deprivation.
Tumor hypoxia activates the hypoxia signaling pathway, promoting angiogenesis, metabolic reprogramming, immune evasion, metastasis, and resistance to therapy. Hypoxia biomarkers are therefore critical in oncology research and drug development.
Key genes include HIF1A, EPAS1 (HIF2A), VEGFA, VHL, EGLN1 (PHD2), LDHA, GLUT1 (SLC2A1), and other hypoxia-responsive targets involved in angiogenesis and metabolism.
Hypoxia signaling activity can be assessed by measuring gene expression of HIF regulators, angiogenic factors, metabolic enzymes, and downstream transcriptional targets using targeted gene expression approaches such as qPCR pathway arrays.
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Hypoxia | HY1H1 |
|
Hypoxia | HY2H1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Hypoxia | HY1M1 |
|
Hypoxia | HY2M1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Hypoxia | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Hypoxia | ******* |
Biomarker list in progress. |
Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.
1. Lee JW et al. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. (2019);51(6):1-13.
2. Tirpe AA et al. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. Int J Mol Sci. (2019);20(24):6140.
3. Yuen VW, Wong CC. Hypoxia-inducible factors and innate immunity in liver cancer. J Clin Invest. (2020);130(10):5052-5062.
4. Yeo EJ. Hypoxia and aging. Exp Mol Med. (2019);51(6):1-15.
5. Serebrovska ZO et al. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. (2020);41(12):1539-1546.